No Carolina / New York / Florida        Ph: 561.316.3330

Pall Corporation and Single Use Support Partner to Safeguard Storage and Transport Critical Biopharmaceuticals

What To Know

  • Pall Corporation, a global leader in filtration, separation, and purification, announced a strategic partnership with Single Use Support GmbH, a leading provider of an innovative, end-to-end solution for safe handling of biologics from bulk manufacturing to fill-finish.
  • Through our partnership with Single Use Support, Pall will be able to offer the Biopharma industry a fully validated end-to-end solution, which will enable our customers to bring life-saving drugs to the patient in a more efficient way,”.

December 16, 2020

Pall Corporation, a global leader in filtration, separation, and purification, announced a strategic partnership with Single Use Support GmbH, a leading provider of an innovative, end-to-end solution for safe handling of biologics from bulk manufacturing to fill-finish.

Pall Corporation will provide significant investment and partner with Single Use Support to distribute the RoSS platform which enhances Pall’s integrated solutions and will make the RoSS platform more accessible to Biopharma customers around the globe.

“Safe and reliable management of drug substances is a challenge for many Pall customers. Through our partnership with Single Use Support, Pall will be able to offer the Biopharma industry a fully validated end-to-end solution, which will enable our customers to bring life-saving drugs to the patient in a more efficient way,” explained Ed Hoare, Vice President and General Manager, Pall Corporation.

Single-Use Support’s RoSS platform consists of an innovative workflow solution, combining robust RoSS shells to protect single-use biocontainers, such as Pall’s Allegro™ biocontainer bags, throughout the process with systems allowing automated filling, controlled freezing/thawing and safe transportation.

“Through high-value liquid management systems, we help our customers safeguard a step that, while inefficient, is mission-critical in bioprocessing,” said Johannes Kirchmair, co-founder and Managing Director of Single Use Support.

Thomas Wurm, co-founder and Managing Director of Single Use Support further explained, “Pall is a global science and technology innovator and shares our mission to help customers solve complex challenges to improve quality of life around the world. Pall Corporation holds an unparalleled leadership position in bioprocessing technologies. Through our partnership, our innovative solution will become more accessible to customers worldwide.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

A significant review found that a staggering 77.2% of nurses experience Work-Related Musculoskeletal Disorders within a year. This high incidence rate highlights the physical strain of nursing duties, which often include extended periods of standing, and underscores the need for effective interventions.
A clinical asset management evaluation will provide executives with valuable insights and recommendations, empowering them to enhance the organization’s long-term effectiveness, safety, and cost-efficiency. Read what our expert has to say.
Did you know clinician burnout remains a significant challenge for health systems and patients alike with over 50% of clinicians reporting feelings of burnout, largely attributed to manual documentation and administrative burdens? Read what Mr. Krakaris has to say.
When it was first announced, Apple Vision Pro was widely heralded as the savior of the VR/XR dream. Would Apple do to the spatial computing market what it did to the mobile phone market in the late noughties? What is the reality now that the device is launched – what does it mean for the business world’s adoption and effective utilization of spatial computing, and more specifically for our customers who are focused on surgical education and medical device sales and adoption? Read on.
Chuck Serrin advises since the pandemic, there has been a rise in ordering everything to the home - from vitamins to prescription drugs - and the days of venturing to a brick-and-mortar store are declining. The pharmaceutical industry is no different. It too is evolving, and pharmacy-focused businesses must make sure their systems are updated to keep up with the changing times.

By using this website you agree to accept Medical Device News Magazine Privacy Policy